Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Invested Capital (2019 - 2025)

Korro Bio (KRRO) has disclosed Invested Capital for 6 consecutive years, with $99.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 44.87% year-over-year to $99.0 million, compared with a TTM value of $99.0 million through Sep 2025, down 44.87%, and an annual FY2024 reading of $160.4 million, down 5.59% over the prior year.
  • Invested Capital was $99.0 million for Q3 2025 at Korro Bio, down from $115.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $198.1 million in Q2 2024 and bottomed at -$153.3 million in Q3 2023.
  • Average Invested Capital over 5 years is $78.2 million, with a median of $116.0 million recorded in 2022.
  • Peak annual rise in Invested Capital hit 290.84% in 2023, while the deepest fall reached 269.71% in 2023.
  • Year by year, Invested Capital stood at -$41.4 million in 2021, then crashed by 115.18% to -$89.0 million in 2022, then soared by 290.84% to $169.9 million in 2023, then dropped by 5.59% to $160.4 million in 2024, then plummeted by 38.27% to $99.0 million in 2025.
  • Business Quant data shows Invested Capital for KRRO at $99.0 million in Q3 2025, $115.1 million in Q2 2025, and $139.0 million in Q1 2025.